OrthoD, manufacturer and distributor of single-use orthopaedic devices, was acquired by private equity firm Apposite Capital. Terms were not disclosed.
RTI Surgical reached a global milestone of >8 million biologic implants processed through proprietary sterilization, with no confirmed incidence of implant-associated infection.
NN entered into a definitive agreement to acquire Paragon Medical for US $375MM in cash. For 2017, Paragon posted revenue of $141.0MM. The transaction is slated to close during 2Q18.
Nanovis received FDA 510(k) clearance to market FortiCore® interbody fusion devices that feature a Nanosurface-enhanced porous titanium scaffold, intermolded with a PEEK core.
Study results demonstrate that RTI Surgical's Simmetry® Sacroiliac Joint Fusion system provided effective joint fixation, markedly reducing range of motion in the SI joint.